Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

An investigation of the neurological relevance of patient-reported executive dysfunctions and underestimation of executive dysfunctions in people with multiple sclerosis

EF 2022-23

Résumé
Background: Executive dysfunctions (EDFs; such as impaired planning, reasoning, etc.) are important for daily functioning and quality of life for people with multiple sclerosis (MS). It is thought that people with MS are unaware of their cognitive impairments as patient-reported general cognition is poorly related to objective cognitive performance. This may not apply to EDFs as patient-reported EDFs are moderately related to objectively-measured EDFs. Underestimation of EDFs may also have utility as underestimation of other cognitive impairments are related to more severe cognitive impairment. Although objectively measured EDFs relate to greater brain pathology in MS, it is unclear if that is true of patient-reported EDFs and underestimation of EDFs. Objectives: The current study aims to (i) examine the relationship between patient-reported EDFs in MS and a biomarker of brain pathology (retinal optical coherence tomography; OCT); and (ii) assess the relationship between underestimation of EDFs and brain pathology. Methods: EDFs will be assessed in people with MS through the Stroop test and the Neuro-Qol-EF. Underestimation of EDFs will be measured as patient-reported EDFs which indicate less EDF than what is indicated by objective cognitive performance. Analyses will examine (i) the relationship between patient-reported EDFs and OCT metrics most associated with objectively-measured cognitive dysfunctions and brain pathology; and (ii) the extent to which underestimation of EDF accounts for this relationship. Significance: If patient-reported EDFs and underestimation of EDFs are neurologically relevant, the use of quick and easy to administer patient-reported EDF measures will be supported to meet some clinical/research needs.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486200
Name
Peters Aidan L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
An investigation of the neurological relevance of patient-reported executive dysfunctions and underestimation of executive dysfunctions in people with multiple sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cognitive Performance; Executive Functioning; Inhibition; Metacognition; Multiple Sclerosis; Patient-Reported Outcomes; Self-Awareness
Abstract
Background: Executive dysfunctions (EDFs; such as impaired planning, reasoning, etc.) are important for daily functioning and quality of life for people with multiple sclerosis (MS). It is thought that people with MS are unaware of their cognitive impairments as patient-reported general cognition is poorly related to objective cognitive performance. This may not apply to EDFs as patient-reported EDFs are moderately related to objectively-measured EDFs. Underestimation of EDFs may also have utility as underestimation of other cognitive impairments are related to more severe cognitive impairment. Although objectively measured EDFs relate to greater brain pathology in MS, it is unclear if that is true of patient-reported EDFs and underestimation of EDFs. Objectives: The current study aims to (i) examine the relationship between patient-reported EDFs in MS and a biomarker of brain pathology (retinal optical coherence tomography; OCT); and (ii) assess the relationship between underestimation of EDFs and brain pathology. Methods: EDFs will be assessed in people with MS through the Stroop test and the Neuro-Qol-EF. Underestimation of EDFs will be measured as patient-reported EDFs which indicate less EDF than what is indicated by objective cognitive performance. Analyses will examine (i) the relationship between patient-reported EDFs and OCT metrics most associated with objectively-measured cognitive dysfunctions and brain pathology; and (ii) the extent to which underestimation of EDF accounts for this relationship. Significance: If patient-reported EDFs and underestimation of EDFs are neurologically relevant, the use of quick and easy to administer patient-reported EDF measures will be supported to meet some clinical/research needs.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peters, Aidan L
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~